We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Rejects Merck's Latest COX-2 Drug

Law360 (April 30, 2007, 12:00 AM EDT) -- The U.S. Food and Drug Administration has rejected Merck & Co.’s bid for approval of its painkiller and osteoarthritis treatment Arcoxia, a drug that is in the same class as Vioxx,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.